The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review.

Kiebert, G.M.; Haes, J.C.J.M. de; Velde, C. J. H. van de

doi:10.1200/jco.1991.9.6.1059

Cited by 308 publications

(164 citation statements)

References 0 publications

Supporting

Mentioning

136

Contrasting

Unclassified

Order By: Relevance

“…This supports the utility of the BIS for differentiating surgery groups characterized by different appearance changes. This finding is in line with previous research (Bloom et al, 1998;Fallowfield et al, 1986;Kiebert et al, 1991;Yilmazer et al, 1994) and also with the results of Hopwood et al (2001).…”

Section: Discussionsupporting

confidence: 93%

The Portuguese version of the Body Image Scale (BIS) – psychometric properties in a sample of breast cancer patients

Moreira

Silva

Marques

et al. 2010

European Journal of Oncology Nursing

View full text Add to dashboard Cite

Keywords:Body image scale Instrument Body image Cancer Portuguese version EORTC Breast cancer a b s t r a c t Purpose: The aim of this study was to analyse the psychometric properties of the Portuguese version of the body image scale (BIS; Hopwood, P., Fletcher, I., Lee, A., Al Ghazal, S., 2001. A body image scale for use with cancer patients. European Journal of Cancer, 37,[189][190][191][192][193][194][195][196][197]. This is a brief and psychometric robust measure of body image for use with cancer patients, independently of age, cancer type, treatment or stage of the disease and it was developed in collaboration with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Study Group. Method: The sample is comprised of 173 Portuguese postoperative breast cancer patients that completed a battery of measures that included the BIS and other scales of body image and quality of life, in order to explore its construct validity. Results: The Portuguese version of BIS confirmed the original unidimensional structure and demonstrated adequate internal consistency, both in the global sample (a ¼ .93) as in surgical subgroups (mastectomy ¼ .92 and breast-conserving surgery ¼ .93). Evidence for the construct validity was provided through moderate to largely sized correlations between the BIS and other related measures. In further support of its discriminant validity, significant differences in BIS scores were found between women who underwent mastectomy and those who underwent breast-conserving surgery, with the former presenting higher scores. Age and time since diagnosis were not associated with BIS scores. Conclusions: The Portuguese BIS proved to be a reliable and valid measure of body image concerns in a sample of breast cancer patients, allowing a brief and comprehensive assessment, both on clinical and research settings.

show abstract

Section: Discussionsupporting

confidence: 93%

The Portuguese version of the Body Image Scale (BIS) – psychometric properties in a sample of breast cancer patients

Moreira

Silva

Marques

et al. 2010

European Journal of Oncology Nursing

View full text Add to dashboard Cite

show abstract

“…However, women whose breasts are preserved have more positive attitudes about their body image and experience fewer changes in their frequency of breast stimulation and feelings of sexual desirability. 66,67 …”

Section: Patient Preferencesmentioning

confidence: 99%

Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma

Morrow

Strom

Bassett

et al. 2002

CA: A Cancer Journal for Clinicians

301

165

View full text Add to dashboard Cite

Multidisciplinary guidelines for management of invasive breast carcinoma from the American College of Radiology, the American College of Surgeons, the College of American Pathology, and the Society of Surgical Oncology have been updated to reflect the continuing advances in the diagnosis and treatment of invasive breast cancer. The guidelines provide a framework for clinical decision‐making for patients with invasive breast carcinoma based on review of relevant literature and include information on patient selection and evaluation, technical aspects of surgical treatment, techniques of irradiation, and follow‐up care.

show abstract

“…Other explanations for the differences found were the woman's age at diagnosis (older women were less likely to undergo BCS) (Silliman et al, 1989;Cady and Stone, 1990;Farrow et al, 1992;Ganz, 1992;Satariano et al, 1992;Howe et al, 1995), geography (Cady and Stone, 1990;Ferguson et al, 1990;Farrow et al, 1992;Howe et al, 1995), and the availability of radiotherapy (Cady and Stone, 1990). Also, physician preference (Cady and Stone, 1990;Long, 1993), tumour size (Delouche et al, 1987;Cady and Stone, 1990;Margolese, 1995), the patient's own personal preferences (Cady and Stone, 1990), local medical customs and practices (Cady and Stone, 1990;Kiebert et al, 1991;Margolese, 1995), and co-morbidity (Satariano, 1992) all influence the choice of surgical procedure. Because we were able to use data on surgical procedures and length of stay from a national database, the treatment algorithms that we have developed incorporate the above-mentioned variations in practice patterns and surgical choices into the national average.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs

et al. 1999

View full text Add to dashboard Cite

In an era of fiscal restraint, it is important to evaluate the resources required to diagnose and treat serious illnesses. As breast cancer is the major malignancy affecting Canadian women, Statistics Canada has analysed the resources required to manage this disease in Canada, and the associated costs. Here we report the cost of initial diagnosis and treatment of nonmetastatic breast cancer, including adjuvant therapies. Treatment algorithms for Stages I, II, and III of the disease were derived by age group (< 50 or ≥ 50 years old), principally from Canadian cancer registry data, supplemented, where necessary, by the results of surveys of Canadian oncologists. Data were obtained on breast cancer incidence by age, diagnostic work-up, stage at diagnosis, initial treatment, follow-up practice, duration of hospitalization and direct care costs. The direct health care costs associated with ‘standard’ diagnostic and therapeutic approaches were calculated for a cohort of 17 700 Canadian women diagnosed in 1995. Early stage (Stages I and II) breast cancer represented 87% of all incident cases, with 77% of cases occurring in women ≥ 50 years. Variations were noted in the rate of partial vs total mastectomy, according to stage and age group. Direct costs for diagnosis and initial treatment ranged from $8014 for Stage II women ≥ 50 years old, to $10 897 for Stage III women < 50 years old. Except for Stage III women < 50 years old, the largest expenditure was for hospitalization for surgery, followed by radiotherapy costs. Chemotherapy was the largest cost component for Stage III women < 50 years old. This report describes the cost of diagnosis and initial treatment of nonmetastatic breast cancer in Canada, assuming current practice patterns. A second report will describe the lifetime costs of treating all stages of breast cancer. These data will then be incorporated into Statistics Canada's Population Health Model (POHEM) to perform cost-effectiveness studies of new therapeutic interventions for breast cancer, such as the cost-effectiveness of day surgery, or of radiotherapy to all breast cancer patients undergoing breast surgery. © 1999 Cancer Research Campaign

show abstract

The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review.

Cited by 308 publications

References 0 publications

The Portuguese version of the Body Image Scale (BIS) – psychometric properties in a sample of breast cancer patients

The Portuguese version of the Body Image Scale (BIS) – psychometric properties in a sample of breast cancer patients

Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs

Contact Info

Product

Resources

About